Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Radiology
Volume 2017 (2017), Article ID 9159035, 9 pages
https://doi.org/10.1155/2017/9159035
Case Report

Extraosseous Multiple Myeloma: Case Report of Presentation in the Lower Extremity Soft Tissues with Literature Review

1Department of Radiology, University of Minnesota, Minneapolis, MN, USA
2Musculoskeletal Division, Department of Radiology, University of Minnesota, Minneapolis, MN, USA

Correspondence should be addressed to Takashi Takahashi; ude.nmu@500sakat

Received 20 August 2017; Revised 7 November 2017; Accepted 20 November 2017; Published 17 December 2017

Academic Editor: Roberto Iezzi

Copyright © 2017 Jeff Ames et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Hanrahan, C. R. Christensen, and J. R. Crim, “Current concepts in the evaluation of multiple Myeloma with MR imaging and FDG PET/CT,” RadioGraphics, vol. 30, no. 1, pp. 127–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Touzeau and P. Moreau, “How i treat extramedullary myeloma,” Blood, vol. 127, no. 8, pp. 971–976, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Ferraro, A. Agarwal, E. L. Martin-Macintosh, P. J. Peller, and R. M. Subramaniam, “MR imaging and PET/CT in diagnosis and management of multiple myeloma,” RadioGraphics, vol. 35, no. 2, pp. 438–454, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Kumar, S. V. Rajkumar, A. Dispenzieri et al., “Improved survival in multiple myeloma and the impact of novel therapies,” Blood, vol. 111, no. 5, pp. 2516–2520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Weinstock and I. M. Ghobrial, “Extramedullary multiple myeloma,” Leukemia & Lymphoma, vol. 54, no. 6, pp. 1135–1141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Z. Usmani, C. Heuck, A. Mitchell et al., “Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents,” Haematologica, vol. 97, no. 11, pp. 1761–1767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Rasche, S. S. Chavan, O. W. Stephens et al., “Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing,” Nature Communications, vol. 8, no. 1, 2017. View at Publisher · View at Google Scholar
  8. J. C. Regelink, M. C. Minnema, E. Terpos et al., “Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review,” British Journal of Haematology, vol. 162, no. 1, pp. 50–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. V. Rajkumar, M. A. Dimopoulos, and A. Palumbo, “International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma,” The Lancet Oncology, vol. 15, no. 12, pp. e538–e548, 2014. View at Publisher · View at Google Scholar
  10. M. Cavo, E. Terpos, C. Nanni et al., “Role of 18 F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group,” The Lancet Oncology, vol. 18, no. 4, pp. e206–e217, 2017. View at Publisher · View at Google Scholar